Picture of Embecta logo

EMBC — Embecta News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Embecta Corp reports results for the quarter ended December 31 - Earnings Summary

* Embecta Corp  EMBC.OQ  reported quarterly adjusted
earnings of
65 cents​​ per share for the quarter ended December 31, higher
than the same quarter last year, when the company reported EPS
of 61 cents.  The mean expectation of four analysts for the
quarter was for earnings of 44 cents per share. Wall Street
expected results to range from 43 cents to 46 cents per share.
    * Revenue fell 5.6% to $261.90 million from a year ago;
analysts
expected $254.62 million. 
    * Embecta Corp's reported EPS for the quarter was breakeven
results​.
    * The company reported break even results for the quarter.
    * Embecta Corp shares had fallen by 11.9% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 21.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Embecta Corp is
$20.00 
This summary was machine generated from LSEG data February 6 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      0.44           0.65           Beat
 Sep. 30 2024      0.36           0.45           Beat
 Jun. 30 2024      0.46           0.74           Beat
 Mar. 31 2024      0.40           0.67           Beat

Recent news on Embecta

See all news